AMIKALYF-500 Injection | Amikacin Sulphate Injection IP

Price:

113.00

Amikacin Sulphate Injection IP

Packaging – 20 ml Vial

Categories: ,

Description

Product Description

AMIKALYF-500 Injection contains Amikacin Sulphate, an antibiotic used to manage a variety of serious bacterial infections. It works by stopping the growth of bacteria and helping the body control infections effectively.

This injection is commonly prescribed for infections affecting the lungs, urinary tract, blood, bones, joints, and skin, supporting faster recovery and improved health under medical supervision.

Uses

  • Respiratory tract infections
  • Urinary tract infections
  • Bloodstream infections
  • Skin and soft tissue infections
  • Bone and joint infections

Benefits

  • Helps control bacterial infections effectively
  • Supports faster recovery from infections
  • Helps reduce infection-related symptoms
  • Supports improved overall health

Composition

  • Amikacin Sulphate
    Amikacin is an aminoglycoside antibiotic that works by stopping the growth of bacteria responsible for infections.

Dosage

  • Administered by a healthcare professional.
  • Dosage and duration depend on the patient’s condition and medical advice.

Side Effects

Some individuals may experience mild side effects such as:

  • Nausea
  • Vomiting
  • Injection site pain
  • Headache

If any side effects persist or worsen, consult a healthcare professional.

Storage

  • Store in a cool and dry place
  • Protect from direct sunlight
  • Keep out of reach of children

Safety Information

  • Use only under medical supervision
  • Do not self-administer
  • Inform your doctor about any existing medical conditions or medications

Uses

  1. Musculoskeletal Disorders
  2. Arthritis
  3. Low Back Pain
  4. Ankylosing Spondylitis

Customer reviews

0
0 ratings
1 Star
0%
2 Star
0%
3 Star
0%
4 Star
0%
5 Star
0%

Reviews

There are no reviews yet.

Be the first to review “AMIKALYF-500 Injection | Amikacin Sulphate Injection IP”

Your email address will not be published. Required fields are marked *